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Abstract There are several protocols in existence that guide
clinicians in the implementation of effective, evidence-based
psychological interventions for eating disorders. These have
been made accessible in the form of treatment manuals.
However, relatively few clinicians use those protocols, prefer-
ring to offer more eclectic or integrative approaches.
Following a summary of the research that shows that these
evidence-based approaches can be used successfully in rou-
tine clinical settings, this review considers why there is such
poor uptake of these therapies in such settings. This review
focuses on the role of service culture and on clinicians’ own
attitudes, beliefs and emotions. Possible means of enhancing
uptake are considered, but these cannot be considered to be
ideal solutions at present.
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Introduction
Protocols, usually codified in the form of treatment manuals,
are key methods for the dissemination and reliable implemen-
tation of evidence-based psychological treatments. It is impor-
tant to recognise a protocol for what it is intended to be—a
broad set of methods, designed to be applicable to the patient
in a way that is reflective of their individual case, but guided
by a set of principles. The clinical skill and artistry in the
delivery of evidence-based therapy lie in how the clinician
implements the protocol for the individual patient (1).
However, despite this clear recognition that protocols and
manuals need to be used flexibly, they are perceived negative-
ly by many clinicians (2), who regard them as constraining
their practice and artistry by limiting the individualisation of
formulation and intervention approaches (1). Therapists rou-
tinely deviate from those evidence-based approaches—a phe-
nomenon termed ‘therapist drift’ (3, 4).
Many clinicians argue that evidence-based practice is a
more useful approach than the use of empirically supported
interventions. Evidence-based practice combines those
empirically-supported approaches (usually based on the use
of a protocol/manual) with clinicians’ own judgement and
patients’ values. However, there are two issues to consider
here. First, the evidence to date does not really support the
superiority of this wider ‘evidence-based practice’ approach.
In most cases, clinician judgement results in poorer outcomes
than protocol-based approaches (5, 6), and there is little evi-
dence that the individualised formulations that clinicians de-
velop are clinically reliable or useful to the patient (7). Second,
in eating disorders in particular, patient values are often in
direct conflict with the necessary elements of evidence-
based treatments—for example, the anorexia nervosa sufferer
who wants to achieve recovery (e.g. regaining their health,
completing their education, being able to have children, being
accepted by those around them) whilst remaining at a weight
that makes this impossible, or the bulimia nervosa sufferer
who wants treatment that alleviates their bulimic symptoms
whilst losing weight at the same time. Therefore, one needs to
be wary of the assumption that evidence-based practice (with
its tripartite nature) will be superior to the single element of a
protocolised evidence-based treatment.
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Clinicians working with eating disorders are potentially
fortunate, in that there exists a range of evidence-based proto-
cols that we can use to guide our clinical practice (8–14, 15•,
16, 17). Whilst none of these achieves 100 % success (see
below), they have demonstrable levels of benefit and can be
implemented in routine clinical practice. This review will
briefly consider the evidence that we can treat the eating dis-
orders in research and routine clinical settings, using
protocolised approaches. It will then explore whether we use
those approaches in routine practice and the reasons that we
do or do not do so. Finally, ways in which clinicians might be
encouraged to use evidence-based protocols and methods and
whether such encouragement is likely to be effective will be
considered.
The Evidence Base for Psychological Treatments
for Eating Disorders
Once a protocol has been developed and piloted, evidence-
based treatment requires two major forms of study before it
can be considered to be viable. First, there need to be well-
controlled trials of the protocol in research settings (‘efficacy
studies’). Then, the treatment needs to be tested in routine
clinical settings (‘effectiveness studies’). Both have been car-
ried out in the field of treating eating disorders.
Efficacy Studies
There is clear evidence from large research trials that some
therapies are efficacious in working with eating disorders.
That evidence had been well summarised up until a few years
ago, in the form of a number of reviews with very consistent
conclusions (18–24). A reasonable summary of those reviews
might have led to the following summary, a decade ago:
& A number of therapies had been identified that reduced the
severity and presence of bulimia nervosa and binge-eating
disorder, including cognitive-behavioural therapies
(CBT), interpersonal psychotherapy (IPT), and dialectical
behaviour therapy (DBT). Of those therapies, CBT had
the strongest evidence of the greatest and most rapid
effects.
& Those therapies were usually more effective if delivered in
an individual, face-to-face setting.
& Medications had a limited role in the treatment of eating
disorders, with some evidence for symptom alleviation in
bulimia nervosa and binge-eating disorder, but no support
for treating anorexia nervosa and no clear evidence for
medication/psychotherapy combinations being superior.
The studies were often hard to rely on as indicators of
remission or recovery, as they had very short follow-ups.
& Younger adolescents with less long-lasting cases benefit-
ted more from family-based therapies (FBT).
& Treatments for adults with anorexia nervosa had weak
evidence, with weak outcomes (even when they include
treatments delivered in more intensive settings), and little
difference between therapies.
& There was virtually no evidence base relating to the treat-
ment of atypical eating disorders (other than binge eating
disorder), despite this category representing the largest
single category of eating disorders (19).
Since those reviews were published, a number of important
treatment trials have been published in the field. The key
changes in our evidence base as a result can be summarised as:
& CBT has been shown to be effective in the treatment of
atypical cases of eating disorder where the patient is not
underweight (25), though there is no evidence that there
has been any improvement in outcomes for bulimia
nervosa or binge eating disorder with developments in
CBT.
& Outcomes for patients with anorexia nervosa are some-
what improved, particularly for CBT (26••, 27), though
not in modified versions of CBT where weight gain is
de-emphasised (28). CBT is now demonstrably more ef-
fective than other therapies for this group, at least by the
end of therapy (29, 30). Its effects remain weak compared
to the outcomes for patients who are not underweight,
with recovery in only approximately 30 % of anorexia
nervosa patients entering CBT, but this is better than the
outcomes demonstrated by other therapies (15•, 30, 31).
Other findings in recent years (32) simply reinforce the
conclusions from the earlier literature, as outlined above. It
is particularly noteworthy that there has been little improve-
ment in the outcomes of pharmacotherapy in that time (33). In
particular, it cannot be assumed that combining medication
with psychotherapies is a useful strategy, as the combination
does not reliably add to the benefits of the psychotherapies in
isolation (34).
Finally, it is worth noting that the change in diagnostic
criteria with DSM-5 does not appear to have altered outcome
rates appreciably. However, it does mean that there is some
doubt about the comparability of studies.
Effectiveness
Obviously, it is important to consider whether these evidence-
based treatments can be delivered outside of highly resourced
research settings. A common belief amongst clinicians is that
the results from such research trials cannot be replicated in
routine clinical settings, due to the patients in research settings
being more carefully selected (e.g. to exclude comorbidity),
an unachievable level of supervision and training for thera-
pists, and greater resources being spent on the treatment than
 36 Page 2 of 8 Curr Psychiatry Rep  (2016) 18:36 
in routine practice. However, this is an empirical question—
can the results from clinical research (efficacy) be replicated in
everyday practice (effectiveness)?
Fortunately, the past decade has seen the publication of
several effectiveness studies that give a clear answer to this
question, using large routine clinical populations of patients
with different diagnoses (35–40), and the answer is clear. The
clinical outcomes are very close to those found in research
trials, though the attrition rate is somewhat higher.
Unfortunately, the literature is almost entirely based on CBT.
Therefore, there is a need for more effectiveness studies to
determine whether other evidence-based therapies maintain
that evidence in everyday practice. However, given the lack
of support for common clinician beliefs (e.g. ‘The research
just does not apply here’) relating to the most strongly evi-
denced psychological therapy, one might argue that clinicians
who want to discount other therapies should be required to
make the case that the evidence base cannot be applied in their
place of work.
HowWidely Used Are the Evidence-Based Interventions?
Despite the evidence outlined above, the simple answer to this
question is: ‘Not very widely’. The number of eating-disorder
specialist clinicians who report adhering to evidence-based
protocols and manuals is between 6 and 35 % (41, 42). Far
more clinicians report that they use (un-tested or un-support-
ed) mixtures of some techniques that are derived from empir-
ically supported treatments and some techniques that are not
supported even at that level (41, 43).
Even when clinicians say that they are using an evidence-
based therapy, that claim should be treated with caution. For
example, many clinicians who state that they are delivering
CBTor FBT report that they omit many of the key techniques
that make up those treatments (44, 45, 46•, 47). This omission
is reflected in the accounts of eating-disordered patients
reporting on the treatment that they have received (48•, 49),
as their accounts suggest widely divergent patterns of tech-
niques delivered under the title of CBT.
A further complication is that the same label is used for
therapies with different content. CBT is a classic example of
this issue, with the content differing in important ways. For
example, one might not be surprised that a form of CBT for
anorexia nervosa that reduced or removed the emphasis on
weight gain (the key outcome variable [21]) has relatively
low rates of weight gain (28). Similarly, in recent years, there
has been widespread dissemination of an enhanced form of
CBT (CBT-E [10]), though it has never been compared direct-
ly with the previous form of CBT to determine whether it is
more effective with bulimia nervosa or binge eating disorder.
Indeed, one has to be careful to understand which version of
CBT-E is being used when considering outcomes, as the orig-
inal two versions (broad and focused) have converged into a
single version that combines the focused form with the affect
regulation module of the broad form (50). Finally, studies vary
in how they treat outcomes, with some studies of anorexia
nervosa treating hospitalisation as a routine event and others
as a reason for defining therapy as having failed (26••, 29).
Whilst developments and differences in delivery are clinically
understandable, the key differences need to be highlighted, to
ensure that differences in outcomes can be understood.
To summarise, the number of patients who receive
evidence-based therapies is probably very low, outside of re-
search settings. This pattern of therapist drift and the conse-
quent evidence-practice gap are not confined to eating disor-
ders (3, 4). However, as in other disorders, the gap is a concern
because we have no idea whether it is justified in terms of
patient benefits. Few clinicians document or report on the
outcome of their eclectic or integrationist (or random) ap-
proaches to treatment. The use of individualised approaches
to treatment of eating does not preclude measurement of ef-
fectiveness, but the lack of such measurement does not reas-
sure others that this individual-centred approach is more ef-
fective than a protocol-based approach. Indeed, it is important
to remember that an individual-centred approach based on
clinician judgement has been shown to be substantially less
effective than the use of a protocol-based approach (6).
Therefore, once again, the obligation to demonstrate effective-
ness could be argued to lie with the clinician who adopts the
non-standard approach.
Why Are Evidence-Based Therapies So Rarely
Used for the Eating Disorders?
Difficulties with delivering evidence-based therapies can be
identified at different levels. First, there are service-centred
reasons. Eating disorder services vary in their culture, and
consequently, their willingness to change towards evidence-
based methods. Possibly the best example of service-level
reluctance is that provided by Lowe and colleagues (51),
who attempted to introduce a ‘normalisation of eating’module
into the care package delivered by an existing set of eating
disorder services. They described extreme difficulties in intro-
ducing this element of treatment, facing resistance based on
the staff teams’ and services’ philosophy and practice of care,
even though the administrators of the clinical services had
approved the proposed change.
Second, patient-centred reasons exist for non-use of
evidence-based methods. Patients’ values can conflict with
the delivery of evidence-based treatments. Many patients
who have previously had therapy express a preference for an
approach that is less challenging, omitting key elements such
as weighing and record-keeping (52). Given the degree to
which therapists omit some of the key elements of therapy
(see above), it cannot be a surprise that many eating-
disordered patients have previously had several unsuccessful
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therapies and have become acculturated to the idea that ther-
apy is a relatively unchallenging experience. In short, inade-
quate therapy experiences have the potential to teach patients
that treatment should not be challenging in any way, when it is
clear that the evidence-based approaches are based on chang-
ing ingrained behavioural, social, cognitive and emotional
patterns. Of course, this avoidance of challenging is not con-
fined to the patient, as clinicians also seem to do the same
thing in order to reduce their own anxiety (see below). This
joint pattern is perhaps most clearly seen when the therapist
and patient fall into the pattern of discussing causes of the
eating disorder without engaging in change of the maintaining
factors (e.g. not changing eating patterns).
Finally, there are clinician-centred reasons for non-
delivery of evidence-based approaches. One key reason ap-
plies to psychological therapies in general—many clinicians
(approximately one third) are untrained in the therapy that
they are employed to deliver (53, 54). The second important
reason is the fact that many clinicians’ actions typify the ‘af-
filiation hypothesis’—because one believes in a therapy’s ef-
fectiveness, it will be effective when one uses it. In the case of
the eating disorders, this is a hypothesis that has been com-
prehensively disproved by the work of Poulsen and colleagues
(55••), who have shown that therapists being affiliated to a
psychodynamic approach to treating bulimia nervosa does
not mean that their recovery rate comes even close to the
outcome from evidence-based CBT, even when the psycho-
dynamic therapy is several times longer.
Clinician beliefs and attitudes have a strong influence on
clinical practice. Outside the field of eating disorders, it has
been shown that clinicians’ ratings of their skills and clinical
outcomes indicate that we believe we are far more effective
that we actually are (56–58). There is no reason to assume that
eating disorder clinicians differ from this general pattern of
beliefs. Another clinician-based factor is our knowledge of
and attitudes to protocols and manuals. These vary consider-
ably from clinician to clinician (2, 59), within and outside the
eating disorders. Some clinicians are unaware of the existence
of manuals and protocols and others hold very negative
attitudes towards them. It is also clear that we hold attitudes
to some elements of therapy for eating disorders that are not in
keeping with the evidence about them. For example, some
elements of therapy for eating disorders appear to be
overvalued, such as pre-therapy motivational work (60, 61)
and the presumed universal importance of prioritising the de-
velopment of a strong working alliance in order to facilitate
change (62, 63). In contrast, clinicians undervalue some key
elements of therapy for eating disorders, such as the need to
weigh patients regardless of the specific evidence-based mod-
el (64). Finally, clinicians often hold beliefs about what Meehl
(5) terms ‘broken leg exceptions’—leading us to exclude pa-
tients from evidence-based treatments on the grounds of ap-
parently spurious ‘justifications’. Those ‘justifications’ can
include patient chronicity, comorbidity and complexity, even
though the evidence would not support these as reasons for
such an exclusion or change in practice (65–67).
Clinicians’ emotions are also important in understanding
the delivery of protocols and evidence-based treatment. As
with other disorders (68•), clinicians who are more anxious
are less likely to deliver some of the key elements of treatment
for eating disorders (44, 47). This avoidance of more ‘de-
manding’ elements of therapy has been suggested to be an
example of clinicians engaging in their own safety behav-
iours—avoidance of tasks (e.g. weighing patients; changing
their food intake). Such avoidance means that the clinician
does not feel like a ‘bad therapist’ for distressing the patient,
even though the longer-term result is that the patient does not
improve and the clinician is less effective (4). Meehl (69) has
referred to this ‘protection’ of patients from the demands of
change as reflecting clinicians having a ‘spun glass theory of
the mind’ of their patients—the belief that our making de-
mands of our patients will somehow damage them (like a
fragile spun-glass decoration), even though such protection
means that patients cannot learn to change for the better.
How Could Clinicians Be Encouraged
to Use Evidence-Based Methods?
The mean length of time for research findings to enter into
routine clinical practice is a (perhaps) startling 15–20 years
(70). In some cases, this delay is a matter of ignorance, and in
others, it is a product of resistance at a variety of levels. Whilst
ignorance of the existence of methods to treat different disor-
ders can be overcome relatively easily through didactic
methods, that is not the same as teaching or persuading clini-
cians to use them and to do so appropriately.
Training clinicians is a challenging area (71). Commonly, a
single teaching session of a few hours to two days is treated as
‘training’, even though there is little evidence that this works.
For example, whilst it is known that such sessions can influ-
ence knowledge of and attitudes to exposure therapy, both for
eating disorders and anxiety disorders (72, 73), it is not yet
known whether such changes translate into better use of the
necessary skills in everyday practice. In short, does education
translate into competence, and does competence translate into
adherence to protocols and hence to more effective treatment?
For example, many people have learned to drive safely whilst
being closely monitored (competence), but after a short period
of driving without that monitoring their driving deteriorates
(non-adherence).
It is commonly assumed that clinical supervision is a means
of ensuring that clinicians should adhere to best quality prac-
tice. However, there are some worrying caveats to that as-
sumption. First, does the supervisor have an adequate grasp
of the necessary evidence and skills base to be able to teach the
supervisee to be adherent? Given the time it takes for evidence
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to reach practice (70) and the number of clinicians who lack
training in the therapy that they deliver (53, 54, 55••), ade-
quate supervision is an optimistic assumption in many cases.
Second, do supervisors appraise their supervisees’ skills accu-
rately? Whilst this question has not been investigated in the
field of eating disorders, it has been considered elsewhere, and
the worrying conclusion is that supervisors substantially over-
rate their supervisees’ clinical skills (74), with the likely result
that the therapist continues to drift off-protocol. Clearly, fur-
ther research is needed to help us to understand whether or not
we can trust in the value of supervision to ensure the delivery
of protocolized, evidence-based therapies for eating disorders,
but the evidence to date is not promising.
Of course, a strong means of persuading clinicians to
change their practice should be to require them to attend to
patient outcomes. The existing effectiveness studies (35–40)
show that such outcomes are easily collected, and yet few
services collect or respond to such information. In part, that
poor response might be the product of a lack of research/audit
skills or dedicated time, either of which could be rectified.
However, evidence from outside the field of eating disorders
(75) points to a more worrying fact—that clinicians vary
substantially in their interest or willingness to attend to outcome
data. If data are regarded as being irrelevant, inconvenient or
challenging, then the danger is that clinicians will ignore rather
than respond to them (76).
Where clinicians do attend to data, it is important that they
should be encouraged to attend to the most clinically mean-
ingful data. In the case of eating disorders, those key data
appear to be those that demonstrate early change and symp-
tom remission. There is clear evidence that behavioural and
attitudinal change in the first few sessions of CBT is a critical
indicator of subsequent improvement of eating disorder symp-
toms (77, 78, 79••, 80••). However, whilst it is necessary, early
change is not sufficient in isolation. It is also important to
target some features by the end of treatment (e.g. normalisa-
tion of body image, improvement in psychosocial function), to
reduce the risk of relapse (81).
Conclusion
There have been substantial advances in the treatment of eat-
ing disorders, based on the development and establishment of
evidence-based approaches. Such approaches are codified in
the form of manualised protocols (8–14, 15•, 16, 17), which
can be used with high levels of success in routine clinical
settings (35–40). Indeed, the rate of success with protocol-
based approaches is likely to be higher than that with ap-
proaches that prioritise our clinical judgement (1, 6).
However, this review has identified a serious gap in our use
of research to drive everyday practice when working with
eating disorders. Clinicians use evidence-based approaches,
manuals and protocols rarely (41–45, 46•, 47, 48•)—a failure
that can be attributed to our lack of knowledge, negative atti-
tudes and emotional characteristics (47, 82). At present, a
reliance on training and supervision to ensure competence
and adherence is probably best described as an act of faith,
requiring more clarity about what the training and supervision
should contain. Our patients would benefit if clinicians and
supervisors were to focus on clinical outcomes and the better
implementation of protocols, to improve the level of patient
improvement and recovery.
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